Beyond statistical thresholds: Mapping sequential ATN cascade transitions via brain structural topography in Alzheimer’s disease
- 25 September 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (39)
Abstract
Alzheimer’s disease is widely conceptualized as a biological continuum initiated by amyloid-β (Aβ) accumulation, followed by tau aggregation and neurodegeneration. Although the ATN framework is commonly used to define disease stages, its static biomarker categories may not fully capture the dynamic pathological transitions that determine the optimal window for anti-Aβ therapies. Here, we introduce a Biological Continuum framework that distinguishes dynamic pathological cascades from static biomarker categories. Using neuroimaging-derived brain network topology, we identify four reproducible subgroups that exhibit distinct biological processes, biomarker signatures, and longitudinal cognitive trajectories. Integrated proteomic analyses suggest that these subgroups reflect sequential molecular transitions corresponding to early vulnerability, initiation, amplification, and terminal stages. Post hoc analysis indicates that slower cognitive decline after amyloid-targeting treatment was observed mainly in the initiation stage group. These findings provide a biologically grounded stratification system that captures disease dynamics overlooked by threshold-based models and offers mechanistic insight into the timing of anti-Aβ therapies.Keywords
Funding Information
- National Natural Science Foundation of China (T2425027)
- National Natural Science Foundation of China (82401858)
- National Natural Science Foundation of China (62333002)
- Beijing University of Posts and Telecommunications (2025KYQD22)
This publication has 41 references indexed in Scilit:
- A Multiform Heterogeneity Framework for Alzheimer’s Disease Based on Multimodal NeuroimagingBiological Psychiatry, 2024
- Multiomics Reveals Biological Mechanisms Linking Macroscale Structural Covariance Network Dysfunction With Neuropsychiatric Symptoms Across the Alzheimer’s Disease ContinuumBiological Psychiatry, 2024
- A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional studyeClinicalMedicine, 2023
- Morphological connectivity differences in Alzheimer's disease correlate with gene transcription and cell‐typeHuman Brain Mapping, 2023
- Four Distinct Subtypes of Alzheimer’s Disease Based on Resting-State Connectivity BiomarkersBiological Psychiatry, 2022
- Regional Radiomics Similarity Networks Reveal Distinct Subtypes and Abnormality Patterns in Mild Cognitive ImpairmentAdvanced Science, 2022
- Cortical patterning of morphometric similarity gradient reveals diverged hierarchical organization in sensory-motor corticesCell Reports, 2021
- Disentangling Heterogeneity in Alzheimer’s Disease and Related Dementias Using Data-Driven MethodsBiological Psychiatry, 2020
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- Mild Cognitive ImpairmentArchives of Neurology, 2009